Available
reducing reliance on large cleanroom infrastructure
Making personalized medicine a reality
Empowering the Future of Cell & Gene Therapy.
Pioneering decentralized ATMP manufacturing to bring life-saving therapies closer to the patient.
Innovation Rooted in Greece, Impacting the World.
Theracell Laboratories is a biotechnology company advancing cell and gene therapies. We develop, establish, and manufacture Advanced Therapy Medicinal Products (ATMPs) that meet the highest regulatory standards.
By building scalable and cost-effective manufacturing capacity, we help address one of the industry's key challenges: making advanced therapies more accessible to patients.
Our Core Expertise
Specialized in advanced therapy development and manufacturing.
Theracell Laboratories combines deep scientific expertise with industrial-grade manufacturing capabilities across the full ATMP lifecycle.
01
End-to-End ATMP Development
From scientific discovery to clinical-grade production.
02
Cell & Tissue Therapies
Autologous cell therapies, immunotherapies, and tissue engineering.
03
Therapy-Agnostic Platforms
Adaptable to a wide range of ATMP products.
04
GMP-Compliant Processing
Manufacturing living therapies under the highest regulatory standards.
05
Automated Closed Systems
Reducing risk, manual handling, and manufacturing costs.
Technology
Redefining ATMP Production Through Decentralized Manufacturing.
Traditional decentralized manufacturing by nature entails complex workflows, higher costs, and increased logistical demands. Theracell Laboratories uses a decentralized model that brings automated production closer to the point of care.
Our Mobile Processing Units and Labs are modular, fast-deploying facilities designed for use at hospitals and POCare sites. By using automated closed systems, we reduce human intervention, improve reproducibility, and support safe scale-up under GMP conditions.
Affordable
lowering logistics, processing, and batch-related costs
Accessible
bringing advanced therapies closer to patients
Cells processed in our systems are continuously monitored in standardized environments to ensure high quality, safety, and rapid availability.
What Are ATMPs?
A new era in medicine.
Advanced Therapy Medicinal Products, including cell and gene therapies, represent a new era in medicine. Unlike traditional drugs, ATMPs use living cells or genetic technologies to target disease at its cellular or genetic root.
These therapies may involve processing and engineering of patient's own cells, then returning them to the body to perform a specific therapeutic function.
ATMPs include treatments such as CAR-T therapies, Tumor Infiltrating Lymphocytes, Mesenchymal Stem Cells, gene addition, and gene editing approaches.
Partnerships
Join the Global POCare Network
Collaboration is central to our decentralized model. Theracell Laboratories partners with hospitals, medical centers, academic institutions, research organizations, and biotechnology companies worldwide.
Through our Point of Care Network, partners gain access to a harmonized manufacturing framework supported by quality assurance, regulatory guidance, training, and digital infrastructure.
Who We Partner With
Hospitals and Medical Centers
We help healthcare facilities expand their on-site ATMP manufacturing capabilities using scalable, high-quality processing solutions.
Academic Research Institutes
We support researchers in translating cell and gene therapy discoveries into clinical-grade products for trials and future commercialization.
Biotechnology Companies
We provide biotech developers with a flexible, scalable, and cost-effective alternative to traditional centralized manufacturing models.
Contact
Thank you for your interest. For general questions, business enquiries, or potential collaborations, please reach out to our team using the form below.
Email
info@theracell.com